NCT04891198 2026-03-25
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
3D Medicines
Emory University
Jiangsu HengRui Medicine Co., Ltd.
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Tianjin Medical University Second Hospital
Shanghai Jiatan Pharmatech Co., Ltd